Skip to main content
Premium Trial:

Request an Annual Quote

Differences in Genetic Architecture of Dilated Cardiomyopathy in Patients of African, European Ancestry

A study in the Journal of the American Medical Association finds that patients of African ancestry with dilated cardiomyopathy (DCM) are less likely to have gene variants classified as clinically actionable than patients of European origin. Researchers led by investigators at Ohio State University enrolled patients with DCM who self-identified as non-Hispanic Black, Hispanic, or non-Hispanic white between June 7, 2016, and March 15, 2020 at 25 advanced heart failure programs across the US. Using exome sequencing, they examined variants in 36 DCM-linked genes and classified them as pathogenic, likely pathogenic, or variants of uncertain significance. In this cross-sectional study of 1,198 patients, 8.2 percent of patients of African ancestry had variants classified as pathogenic or likely pathogenic, compared to 25.5 percent of European ancestry patients. While one of the reasons for the difference may be that DCM genetic architecture in African-American individuals differs from that of European-ancestry individuals, the authors also note a need for more representation of patients of African ancestry in clinical and reference datasets so that clinicians can make specific recommendations, test at-risk family members and use the data for gene-specific therapies.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.